- Home
- RVMD vs RLI Comparison
RVMD vs RLI Comparison
Compare RVMD & RLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- RLI
- Stock Information
- Founded
- RVMD 2014
- RLI 1965
- Country
- RVMD United States
- RLI United States
- Employees
- RVMD N/A
- RLI N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- RLI Property-Casualty Insurers
- Sector
- RVMD Health Care
- RLI Finance
- Exchange
- RVMD Nasdaq
- RLI Nasdaq
- Market Cap
- RVMD 7.5B
- RLI 6.8B
- IPO Year
- RVMD 2020
- RLI 1985
- Fundamental
- Price
- RVMD $37.81
- RLI $69.96
- Analyst Decision
- RVMD Strong Buy
- RLI Hold
- Analyst Count
- RVMD 13
- RLI 8
- Target Price
- RVMD $68.38
- RLI $78.60
- AVG Volume (30 Days)
- RVMD 3.3M
- RLI 539.8K
- Earning Date
- RVMD 08-06-2025
- RLI 07-21-2025
- Dividend Yield
- RVMD N/A
- RLI 3.70%
- EPS Growth
- RVMD N/A
- RLI N/A
- EPS
- RVMD N/A
- RLI 3.03
- Revenue
- RVMD N/A
- RLI $1,733,218,000.00
- Revenue This Year
- RVMD N/A
- RLI N/A
- Revenue Next Year
- RVMD $226.82
- RLI $5.96
- P/E Ratio
- RVMD N/A
- RLI $23.17
- Revenue Growth
- RVMD N/A
- RLI 8.88
- 52 Week Low
- RVMD $29.17
- RLI $69.16
- 52 Week High
- RVMD $62.40
- RLI $91.15
- Technical
- Relative Strength Index (RSI)
- RVMD 46.33
- RLI 38.75
- Support Level
- RVMD $36.37
- RLI $69.56
- Resistance Level
- RVMD $38.97
- RLI $71.17
- Average True Range (ATR)
- RVMD 1.34
- RLI 1.29
- MACD
- RVMD 0.07
- RLI -0.05
- Stochastic Oscillator
- RVMD 37.26
- RLI 20.41
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About RLI RLI Corp. (DE)
RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety and it derives a majority of its revenue from the Casualty segment.